|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.560 USD | +7.81% |
|
+0.23% | -26.52% |
| 06-30 | ARS Pharmaceuticals, Inc.(NasdaqGM:SPRY) dropped from Russell 2000 Defensive Index | CI |
| 06-29 | ARS Pharmaceuticals, Inc.(NasdaqGM:SPRY) dropped from Russell 2000 Growth-Defensive Index | CI |
| Market Cap | 850M 743M 683M 637M 1.21B 80.94B 1.23B 8.2B 3.19B 39.78B 3.19B 3.12B 137B | P/E 2026 * |
-4.85x | P/E 2027 * | -9.56x |
|---|---|---|---|---|---|
| Enterprise Value | 850M 743M 683M 637M 1.21B 80.94B 1.23B 8.2B 3.19B 39.78B 3.19B 3.12B 137B | EV / Sales 2026 * |
6x | EV / Sales 2027 * | 3.34x |
| Free-Float |
83.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ARS Pharmaceuticals, Inc.
| 1 day | +7.81% | ||
| 1 week | +0.23% | ||
| Current month | +6.87% | ||
| 1 month | -5.62% | ||
| 3 months | +3.13% | ||
| 6 months | -25.50% | ||
| Current year | -26.52% |
| 1 week | 7.9 |  | 8.64 |
| 1 month | 7.5 | | 10.87 |
| Current year | 7.03 | | 13.15 |
| 1 year | 6.66 | | 18.63 |
| 3 years | 2.55 | | 18.9 |
| 5 years | 2.55 | | 18.9 |
| 10 years | 2.55 | | 18.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarina Tanimoto
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/09/2018 |
Robert Bell
CTO | Chief Tech/Sci/R&D Officer | - | 05/08/2015 |
| Chief Executive Officer | 60 | 01/09/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 05/08/2015 | |
Pratik Shah
CHM | Chairman | 56 | 08/11/2022 |
Rajeev Dadoo
BRD | Director/Board Member | 55 | 01/08/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-01 | Free | Chairperson | 898,456 | 0.9048% | ||
| 06-24 | Free | Director | 30,000 | 0.0302% | ||
| 06-24 | Free | Director | 30,000 | 0.0302% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.81% | +0.23% | -48.18% | +27.19% | 850M | |
| +1.70% | +7.41% | +2.50% | +8.22% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +605.33% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.35% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +64.58% | 33.09B | |
| +3.96% | +10.67% | +8.30% | +40.44% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +133.27% | 15.92B | |
| +0.32% | +0.58% | +14.00% | +19.59% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +99.12% | 13.52B | |
| Average | +2.74% | +5.92% | +65.26% | +110.15% | 24.65B | |
| Weighted average by Cap. | +2.09% | +6.53% | +89.69% | +137.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 142M 124M 114M 106M 201M 13.5B 204M 1.37B 532M 6.63B 532M 521M 22.86B | 255M 223M 205M 191M 362M 24.25B 367M 2.46B 955M 11.92B 956M 936M 41.08B |
| Net income | -176M -154M -142M -132M -250M -16.78B -254M -1.7B -661M -8.25B -661M -647M -28.42B | -90.88M -79.45M -73.01M -68.05M -129M -8.65B -131M -876M -341M -4.25B -341M -334M -14.66B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | $8.560 | +7.81% | 1,796,362 |
| 01/07/26 | $7.940 | -0.87% | 1,148,695 |
| 30/06/26 | $8.010 | -6.43% | 1,327,110 |
| 29/06/26 | $8.560 | +0.23% | 1,407,645 |
| 26/06/26 | $8.540 | +6.48% | 5,015,475 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRY Stock
Select your edition
All financial news and data tailored to specific country editions
